Hans-Christian Von Buedingen

Title: The Innovations of Hans-Christian Von Buedingen

Introduction

Hans-Christian Von Buedingen is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of relapsing multiple sclerosis. His innovative approaches have the potential to improve the lives of many patients suffering from this condition.

Latest Patents

One of his key patents is titled "Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase." This patent outlines methods for treating Relapsing Multiple Sclerosis (RMS) by administering approximately 200 mg of fenebrutinib twice daily, or an equivalent amount of a pharmaceutically acceptable salt thereof. This innovative treatment method showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Hans-Christian has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Hans-Christian has collaborated with esteemed colleagues such as Hideki Garren and Edmond Huatung Teng. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking treatments.

Conclusion

Hans-Christian Von Buedingen's work in the field of medicine, particularly in the treatment of relapsing multiple sclerosis, highlights his innovative spirit and dedication to improving patient outcomes. His contributions through patents and collaborations continue to shape the future of medical treatments.